0.52Open0.52Pre Close0 Volume84 Open Interest87.00Strike Price0.00Turnover93.62%IV13.38%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.52Extrinsic Value100Contract SizeAmericanOptions Type0.1351Delta0.0273Gamma148.44Leverage Ratio-0.1908Theta0.0012Rho20.05Eff Leverage0.0185Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet